--- title: "Imugene (IMU) news: convertible notes" url: "https://aibio.space/companies/imugene/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "IMU convertible notes news: Imugene amends CVI convertible notes and issues new warrants. Imugene Ltd (ASX: IMU), Australia." --- IMU Imugene Ltd ASX · Australia # Imugene (IMU) news IMU convertible notes news Debt Financing · 2026-08-21 ## [Imugene amends CVI convertible notes and issues new warrants](https://aibio.space/news/imugene-amends-cvi-convertible-notes-issues-new-warrants/) A$2.1 million of existing notes is redeemed and replaced by new zero-coupon notes, and the remaining notes amortise in five instalments. ## Latest Imugene news We have not published a story on Imugene yet. When there is news, it will appear here. ## Imugene at a glance - **Ticker**: IMU - **Listing**: ASX - **Country**: Australia ### Related companies - [Incannex Healthcare](https://aibio.space/companies/incannex-healthcare/) NASDAQ: IXHL - [Identifai Genetics](https://aibio.space/companies/identifai-genetics/) ASX: ID1 - [Invex Therapeutics](https://aibio.space/companies/invex-therapeutics/) ASX: IXC - [Neuroscientific Biopharmaceuticals](https://aibio.space/companies/neuroscientific-biopharmaceuticals/) ASX: NSB - [LTR Pharma](https://aibio.space/companies/ltr-pharma/) ASX: LTP - [Biotron](https://aibio.space/companies/biotron/) ASX: BIT - [Telix Pharmaceuticals](https://aibio.space/companies/telix-pharmaceuticals/) ASX: TLX - [AdAlta](https://aibio.space/companies/adalta/) ASX: 1AD ### Also on ASX - [Nyrada](https://aibio.space/companies/nyrada/) NYR - [Noxopharm](https://aibio.space/companies/noxopharm/) NOX - [Identifai Genetics](https://aibio.space/companies/identifai-genetics/) ID1 - [Curvebeam AI](https://aibio.space/companies/curvebeam-ai/) CVB - [Polynovo](https://aibio.space/companies/polynovo/) PNV - [Starpharma Holdings](https://aibio.space/companies/starpharma/) SPL ## Questions about Imugene Has Imugene sold convertible notes? Our latest story on this, dated Aug 21, 2026: "Imugene amends CVI convertible notes and issues new warrants". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/imugene-amends-cvi-convertible-notes-issues-new-warrants/). What is the ticker symbol of Imugene? Imugene Ltd trades under the ticker IMU on ASX. Where is Imugene listed? Imugene Ltd is listed on ASX. Our directory also records these other listings: OTC:IUGNF. Which country or territory is Imugene listed under? Our directory records Imugene Ltd under Australia. What does Imugene do? Our directory classifies Imugene Ltd as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Imugene? The ISIN recorded for Imugene Ltd is AU000000IMU9. Does aibio.space cover Imugene? aibio.space lists Imugene Ltd among 2,820 public biotech companies and publishes its news here as stories appear. What is the latest Imugene (IMU) stock news? Our latest story on Imugene, dated Aug 21, 2026: "Imugene amends CVI convertible notes and issues new warrants". A$2.1 million of existing notes is redeemed and replaced by new zero-coupon notes, and the remaining notes amortise in five instalments. [Source](https://aibio.space/news/imugene-amends-cvi-convertible-notes-issues-new-warrants/). Which companies are similar to Imugene? Companies in our directory listed in the same country and business area as Imugene: Incannex Healthcare, Identifai Genetics, Invex Therapeutics, Neuroscientific Biopharmaceuticals, LTR Pharma, Biotron. How can I follow Imugene (IMU) news? Press Follow on this page to add Imugene to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Imugene so far, in Debt Financing. ## Investor discussion: Imugene Members talk about Imugene (IMU). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open ASX:IMU on TradingView](https://www.tradingview.com/symbols/ASX-IMU/). ## Listing details Imugene Ltd is a public biotech or pharmaceutical company listed on ASX under the ticker IMU, recorded under Australia. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Imugene Ltd - **Ticker**: IMU - **Listing**: ASX - **Country or territory**: Australia - **Business scope**: Biotechnology - **ISIN**: AU000000IMU9 - **Other listed symbols**: OTC:IUGNF - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/ASX-IMU/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/imugene/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Imugene (IMU) news: convertible notes", 2026-10-31, https://aibio.space/companies/imugene/